Lantheus (LNTH)
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of hear...
- Open
- 100.700
- High
- 100.955
- Low
- 100.600
- Prev. Close
- 100.680
- Volume
- 1.49M
- Turnover
- 149.89M
- Avg Price
- 100.763
- Bid/Ask Ratio
- --
- Amplitude
- 0.35%
- 52wk High
- 111.860
- Volume Ratio
- 1.86
- Turnover Ratio
- 2.58%
Lantheus Analyst Rating
View moreForecast & Rating
Aug 6, 2026Price forecast
$107.226.45%
Forecast & RatingBuy
11analysts
- Strong buy27.27%
- Buy9.09%
- Hold63.64%
- Sell0.00%
- Strong sell0.00%
News
- businessinsider · Aug 9 at 09:59 AM
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and more
- Market Beat · Aug 7 at 08:41 PM
Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPS
- PR Newswire · Aug 7 at 01:16 PM
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
- MorningStar · Aug 7 at 10:08 AM
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
- TradingKey · Aug 6 at 07:04 AM
Lantheus Q2 2026 Earnings: Revenue Rises Despite Lower PYLARIFY Sales
- Earnings Watch · Aug 6 at 06:46 AM
Lantheus | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 388.18 M
